These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 1423938)

  • 21. Different patterns of release of endothelium-derived relaxing factor and prostacyclin.
    Mitchell JA; de Nucci G; Warner TD; Vane JR
    Br J Pharmacol; 1992 Feb; 105(2):485-9. PubMed ID: 1373103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potentiation of endogenous nitric oxide with superoxide dismutase inhibits platelet-mediated thrombosis in injured and stenotic arteries.
    Meng YY; Trachtenburg J; Ryan US; Abendschein DR
    J Am Coll Cardiol; 1995 Jan; 25(1):269-75. PubMed ID: 7798515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thimerosal blocks stimulated but not basal release of endothelium-derived relaxing factor (EDRF) in dog isolated coronary artery.
    Crack P; Cocks T
    Br J Pharmacol; 1992 Oct; 107(2):566-72. PubMed ID: 1384915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of intravascular platelet aggregation by endothelium-derived relaxing factor: reversal by red blood cells.
    Houston DS; Robinson P; Gerrard JM
    Blood; 1990 Sep; 76(5):953-8. PubMed ID: 2393718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Inhibition of platelet activation by endothelium-derived relaxing factor EDRF/NO and NO releasing dilator substances].
    Bassenge E
    Z Kardiol; 1991; 80 Suppl 5():17-21. PubMed ID: 1776330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiplatelet effects of endothelium-derived relaxing factor and nitric oxide donors.
    Bassenge E
    Eur Heart J; 1991 Nov; 12 Suppl E():12-5. PubMed ID: 1665128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of atherosclerosis on endothelium-dependent inhibition of platelet activation in humans.
    Diodati JG; Dakak N; Gilligan DM; Quyyumi AA
    Circulation; 1998 Jul; 98(1):17-24. PubMed ID: 9665055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sodium nitroprusside, an endothelium-derived relaxing factor congener, increases platelet cyclic GMP levels and inhibits epinephrine-exacerbated in vivo platelet thrombus formation in stenosed canine coronary arteries.
    Rovin JD; Stamler JS; Loscalzo J; Folts JD
    J Cardiovasc Pharmacol; 1993 Oct; 22(4):626-31. PubMed ID: 7505366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of methylmercury (CH3HgCl) on the production of endothelium-derived relaxing factor (EDRF) by cultured human umbilical vascular endothelial cells based on its anti-aggregatory effect on human platelets.
    Ohno M; Kishimoto T; Tada M
    Cell Biol Toxicol; 1995 Dec; 11(6):303-11. PubMed ID: 8788207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EDRF increases cyclic GMP in platelets during passage through the coronary vascular bed.
    Pohl U; Busse R
    Circ Res; 1989 Dec; 65(6):1798-803. PubMed ID: 2555082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries.
    Yao SK; Ober JC; McNatt J; Benedict CR; Rosolowsky M; Anderson HV; Cui K; Maffrand JP; Campbell WB; Buja LM
    Circ Res; 1992 Jan; 70(1):39-48. PubMed ID: 1727687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blockade of voltage-sensitive Ca(2+)-channels markedly diminishes nitric oxide- but not L-S-nitrosocysteine- or endothelium-dependent vasodilation in vivo.
    Travis MD; Hoque A; Bates JN; Lewis SJ
    Eur J Pharmacol; 2000 Nov; 408(3):289-98. PubMed ID: 11090646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential effects of L-arginine on the inhibition by NG-nitro-L-arginine methyl ester of basal and agonist-stimulated EDRF activity.
    Randall MD; Griffith TM
    Br J Pharmacol; 1991 Nov; 104(3):743-9. PubMed ID: 1797335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alkaline buffers release EDRF from bovine cultured aortic endothelial cells.
    Mitchell JA; de Nucci G; Warner TD; Vane JR
    Br J Pharmacol; 1991 Jun; 103(2):1295-302. PubMed ID: 1884092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EDRF and norepinephrine-induced vasodilation in the canine coronary circulation.
    Van Bibber R; Traub O; Kroll K; Feigl EO
    Am J Physiol; 1995 May; 268(5 Pt 2):H1973-81. PubMed ID: 7771547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of aspirin and epinephrine on experimentally induced thrombogenesis in dogs. A parallelism between in vivo and ex vivo thrombosis models.
    Roux SP; Sakariassen KS; Turitto VT; Baumgartner HR
    Arterioscler Thromb; 1991; 11(5):1182-91. PubMed ID: 1911705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding the controversy over the identity of EDRF.
    Feelisch M; te Poel M; Zamora R; Deussen A; Moncada S
    Nature; 1994 Mar; 368(6466):62-5. PubMed ID: 8107883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is there a role for an endothelium-derived relaxing factor in nociception?
    Meller ST; Lewis SJ; Bates JN; Brody MJ; Gebhart GF
    Brain Res; 1990 Oct; 531(1-2):342-5. PubMed ID: 2289134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of MDL 28,133A, a 5-HT2 receptor antagonist, on platelet aggregation and coronary thrombosis in dogs.
    Hsieh CP; Sakai K; Bruns GC; Dage RC
    J Cardiovasc Pharmacol; 1994 Nov; 24(5):761-72. PubMed ID: 7532754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological reactivity of human epicardial coronary arteries: characterization of relaxation responses to endothelium-derived relaxing factor.
    Stork AP; Cocks TM
    Br J Pharmacol; 1994 Dec; 113(4):1099-104. PubMed ID: 7889260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.